// App-Quantinova.ai

556 : External validation of a prediction model of survival after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC).

Researchers

Presenter

  • Axel Bex

Principal Investigators

  • Erik D. van Werkhoven

  • Allard Noe

  • Jose A. Karam

  • Surena F. Matin

  • Vitaly Margulis

  • Grant Stewart

  • Michael D. Staehler

  • Christopher G. Wood

Medical Centers

  • The Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, Netherlands

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Department of Urology, University Hospital Munich-Grosshadern, Ludwig Maximilian University Munich, Munich, Germany

Locations

  • Netherlands

  • United States

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Metastatic Renal Cell Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved